drugset / Trial / NCT00325637

Cilnidipine Effect on High Blood Pressure and Cerebral Perfusion in Ischemic Stroke Patients With Hypertension

NCT00325637

Phase 3 Completed 250 enrolled Boryung Pharmaceutical Co., Ltd
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare the effect of cilnidipine (a calcium channel blocker) and losartan (an angiotensin II receptor blocker) on cerebral blood flow (CBF) and blood pressure in hypertensive patients with a previous ischemic stroke.

Timeline

Start
2005-01
Primary completion
2007-07
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cilnidipine Small molecule 10 mg Oral
Comparator Cilnidipine Small molecule 20 mg Oral